DEFA14A: Colgate-Palmolive Sets Date for 2024 Annual Meeting, Outlines Proposals for Stockholder Vote

Sentiment:

Proxy Statement


Colgate-Palmolive's 2024 Annual Meeting will be held virtually on May 10, 2024, with stockholders voting on director elections, auditor ratification, executive compensation, and a proposal for an independent Board Chairman.

Summary

  • Colgate-Palmolive Company will hold its 2024 Annual Meeting of Stockholders on May 10, 2024, at 10:00 a.m. Eastern Daylight Time.
  • The meeting will be held virtually at www.virtualshareholdermeeting.com/CL2024.
  • Stockholders can vote on several key proposals, including the election of ten directors.
  • The nominees for director are John P. Bilbrey, John T. Cahill, Steve Cahillane, Lisa M. Edwards, C. Martin Harris, Martina Hund-Mejean, Kimberly A. Nelson, Brian Newman, Lorrie M. Norrington, and Noel R. Wallace.
  • Stockholders will also vote to ratify the selection of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm.
  • An advisory vote on executive compensation is also scheduled.
  • Finally, there is a stockholder proposal regarding an independent Board Chairman.
  • The deadline to vote shares held directly is May 9, 2024, at 11:59 PM ET.
  • For shares held in a plan, the voting deadline is May 8, 2024, at 11:59 PM ET.
  • Stockholders can access proxy materials and vote online at www.ProxyVote.com.
  • They can also request a free paper or email copy of the materials by April 26, 2024.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in sentiment. It provides information necessary for shareholders to make informed decisions.

Positives

  • The virtual format of the annual meeting allows for broader accessibility for stockholders.
  • Stockholders have the opportunity to vote on key governance matters, including director elections and executive compensation.
  • The availability of proxy materials online and via mail/email ensures stockholders can make informed decisions.

Future Outlook

The document outlines the agenda and procedures for the upcoming annual meeting, providing stockholders with the opportunity to influence the company's direction through their votes.

Industry Context

Proxy statements and annual meetings are standard practice for publicly traded companies, allowing shareholders to participate in corporate governance.

Comparison to Industry Standards

  • The proposals listed are typical for annual meetings of publicly traded companies.
  • The virtual meeting format is increasingly common, aligning with trends towards greater accessibility and cost-effectiveness.
  • The matters to be voted on are similar to those at Proctor & Gamble and Unilever annual meetings.

Stakeholder Impact

  • Shareholders have the opportunity to influence the company's direction through their votes on key proposals.
  • The outcome of the votes can impact the composition of the board of directors and executive compensation.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals by the relevant deadlines.
  • Attend the virtual annual meeting on May 10, 2024, if desired.

Key Dates

DateDescription
April 26, 2024Deadline to request a free paper or email copy of proxy materials.
May 8, 2024Voting deadline for shares held in a plan (11:59 PM ET).
May 9, 2024Voting deadline for directly held shares (11:59 PM ET).
May 10, 2024Date of the 2024 Annual Meeting of Stockholders (10:00 a.m. Eastern Daylight Time).

Keywords

Annual Meeting, Proxy Statement, Stockholders, Colgate-Palmolive, Voting, Directors, Executive Compensation, Auditor, PricewaterhouseCoopers, Board Chairman, Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.